New York’s mobile betting industry keeps on breaking records. Recently revealed figures show that within the first two weeks of legal online betting, NY sportsbooks took over $600 million in wagers.
The most impressive fact is that from January 8 to January 16, only four mobile sportsbooks were operational in the Empire State. The brands in question are Caesars, FanDuel, DraftKings, and BetRivers.
New York State Breaks New Jersey’s Record
Two weeks ago, we reported that New York mobile sportsbooks had made a fantastic debut, generating a handle of $5.8 million within the first 12 hours of operation. More data became public since, and the numbers show that the New York sportsbooks did even better than expected.
For instance, within the first eight days of legal mobile betting, the four NY sportsbooks made a total revenue for themselves of over $27 million.
Caesars led New York's 4 live mobile sports betting operators during the state's first 8 days after launch:
Caesars: $257.7m handle – $22.7m revenue
FanDuel: $200.4m handle – $14.1m revenue
DraftKings: $134.4m handle – $10.9m revenue
BetRivers: $10.6m handle – $447,000 revenue
— Ryan Butler (@ButlerBets) January 21, 2022
Furthermore, the sportsbooks accepted $603 bets in that period, which accounts for $67 million worth of bets per day. That’s significantly more than what New Jersey sportsbooks generated over the same period in October. Back then, NJ sportsbooks recorded a record $41.9 million per day.
Caesars Sportsbook Leads the Pack
Caesars Sportsbook revealed that it recorded a $527.7 million handle in the first eight days since the launch of its NY mobile/online sportsbook. With so much money wagered by New Yorkers, Caesars was able to generate a revenue of $22.7 million.
When it comes to the fifth NY online sportsbook, BetMGM, which launched on Monday, January 17, we still don’t have official data regarding the revenues. However, as per a BetMGM press release, the sportsbook seems to be doing better than expected. The result is that the company’s revenue projections for 2022 have grown from $1 billion to $1.3 billion.